The aim of cancer prevention is to take actions to reduce cancer prevalence. This includes maintaining a healthy lifestyle, avoiding exposure to known cancer-causing substances, taking medicines or vaccines, and improving cancer screening to prevent cancer progression. Scientists and clinicians have made great progress in cancer therapies in recent decades, which considerably improved patients’ life quality and their survival rate. However, it should be noticed that advanced therapies lead to higher expenses for patients, which is a probable social pressure related to the complexity of addressing cancer. For instance, newer and better medicines entering the market at higher prices, limits access for patients particularly in low- and middle-income countries. Several countries offer financial aid to cancer patients as part of universal health coverage (UHC) program. This requires an increase in health expenditure, the adoption of cost-effective intervention packages, and the construction of infrastructure. In addition, the structure of the healthcare delivery system needs improving in order to guarantee patients’ access to cancer care. There are many social, clinical and economic factors that are associated with cancer prevention and therapy.
Cancer has become a leading cause of disability and mortality in the world. In order to provide sophisticated cancer care, obstruction should be overcome by corresponding institutions. As a result, provisions for timely, equitable and adequate cancer prevention and therapy will become more accessible. It should include cancer screening, surgery, radiotherapy, and novel anti-cancer medicines. Evidence-based healthcare financing and policy for cancer prevention and therapy requires well-specified policies, distinguishing between policies and goals, empirical evidence in the magnitude of effects and consideration of the financial demand of resources. This Research Topic hopes to identify the social, clinical and economic factors that promote the development of evidence-based healthcare financing and policy for cancer prevention and therapy, and to provide specific and practical advice on health policy based on the findings of the empirical studies worldwide.
This Research Topic welcomes all article types available in Frontiers in Public Health including Original Research, Systematic Review, Perspective, Editorial and Study Protocol. We welcome contributions on evidence-based health policy for cancer prevention and therapy on the subtopics below, but not limited to:
1. Costs of novel anti-cancer drugs and clinical benefits
2. Pharmacoeconomic evaluation of novel anti-cancer medicines
3. Impacts of public health policy on the price, utilization, availability and affordability of novel anti-cancer medicines
4. Social, clinical and economic factors for cancer prevention and therapy, and hinder the access to cancer care
5. Public health policies that improve cancer screening and decision-making
6. Current paradigms and recent advances and challenges in universal health coverage for cancer care
The aim of cancer prevention is to take actions to reduce cancer prevalence. This includes maintaining a healthy lifestyle, avoiding exposure to known cancer-causing substances, taking medicines or vaccines, and improving cancer screening to prevent cancer progression. Scientists and clinicians have made great progress in cancer therapies in recent decades, which considerably improved patients’ life quality and their survival rate. However, it should be noticed that advanced therapies lead to higher expenses for patients, which is a probable social pressure related to the complexity of addressing cancer. For instance, newer and better medicines entering the market at higher prices, limits access for patients particularly in low- and middle-income countries. Several countries offer financial aid to cancer patients as part of universal health coverage (UHC) program. This requires an increase in health expenditure, the adoption of cost-effective intervention packages, and the construction of infrastructure. In addition, the structure of the healthcare delivery system needs improving in order to guarantee patients’ access to cancer care. There are many social, clinical and economic factors that are associated with cancer prevention and therapy.
Cancer has become a leading cause of disability and mortality in the world. In order to provide sophisticated cancer care, obstruction should be overcome by corresponding institutions. As a result, provisions for timely, equitable and adequate cancer prevention and therapy will become more accessible. It should include cancer screening, surgery, radiotherapy, and novel anti-cancer medicines. Evidence-based healthcare financing and policy for cancer prevention and therapy requires well-specified policies, distinguishing between policies and goals, empirical evidence in the magnitude of effects and consideration of the financial demand of resources. This Research Topic hopes to identify the social, clinical and economic factors that promote the development of evidence-based healthcare financing and policy for cancer prevention and therapy, and to provide specific and practical advice on health policy based on the findings of the empirical studies worldwide.
This Research Topic welcomes all article types available in Frontiers in Public Health including Original Research, Systematic Review, Perspective, Editorial and Study Protocol. We welcome contributions on evidence-based health policy for cancer prevention and therapy on the subtopics below, but not limited to:
1. Costs of novel anti-cancer drugs and clinical benefits
2. Pharmacoeconomic evaluation of novel anti-cancer medicines
3. Impacts of public health policy on the price, utilization, availability and affordability of novel anti-cancer medicines
4. Social, clinical and economic factors for cancer prevention and therapy, and hinder the access to cancer care
5. Public health policies that improve cancer screening and decision-making
6. Current paradigms and recent advances and challenges in universal health coverage for cancer care
